An international multidisciplinary team has demonstrated for the first time that CRISPR-based gene activation (CRISPRa) can ...

Researchers engineered and screened dozens of base editors to precisely target a single mutation without editing other portions of the DNA.

Scribe highlights latest data on Lp(a)-lowering therapy and novel AI platform for next-generation CRISPR-based therapeutics at two premier conferences ...

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG ...

-CTX310™ led to durable reductions of angiopoietin-like 3 protein (ANGPTL3) and triglyceride levels in non-human primates (NHPs) after a single dose- CRISPR Therapeutics is advancing a pipeline of in ...

Every era of biology has been defined by a tool: the microscope, the sequencer, CRISPR. Artificial intelligence is emerging ...

Health Secretary Robert F. Kennedy picked Prasad to be FDA vaccine regulator. Prasad's social media reveals criticism of Verve's 1st-gen PCSK9 approach, which may signal negative sentiment for CRISPR ...

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

CRISPR Therapeutics reports promising Phase 1 clinical data for CTX310™, with significant triglyceride and LDL reductions, and updates on other programs. CRISPR Therapeutics announced promising new ...

CRISPR Therapeutics (CRSP) presented data from the Company’s ongoing Phase 1/2 dose escalation clinical trial evaluating the safety and efficacy of CTX112, a next-generation CD19 allogeneic CAR T cell ...